Share

Recommendations for FDA's Office of Minority Health and Health Equity (OMHHE)

February 28, 2020

In response to a request from FDA, ACS CAN has provided recommendations for areas of focus for the Office of Minority Health and Health Equity (OMHHE).  Recommendations include assessing the applicability of drug "snapshot" data, evaluating the appropriateness of aggregating racial groups for analysis, and examination of drug classes where differences in metabolism, safety or efficacy are likely to be seen.